Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high ...

Experts from Yale University have uncovered a new, concerning condition linked to the COVID-19 vaccines. Dubbed ...

Long COVID duration did not affect health outcomes; however, COVID-19 vaccination status was associated with better PROMIS ...

COVID-19 vaccines have been instrumental in reducing the impact of the pandemic, preventing severe illness and death, and ...

A Yale University study explores the newly defined post-vaccination syndrome (PVS), revealing alarming biological changes ...

The new five-type index, developed by federal researchers with the National Institutes of Health’s RECOVER COVID Initiative, ...

Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: ...

A newly identified condition, called “post-vaccination syndrome” (PVS), appears to be linked to mRNA Covid vaccines.

Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...

Pembrolizumab is a checkpoint inhibitor that binds to the protein PD-1 on T cells to help them recognize and attack invaders.